Local treatment of pharyngitis in children

Abstract

Acute respiratory diseases (ARDs) rank first in the structure of the total incidence as confirmed by the World Health Organization newsletters, and remain a serious problem for the healthcare and economy of different countries nowadays. Therefore, a rational approach to their treatment is important for each practicing pediatrician. Every 15–20 years, there are major changes in the structure of the main pathogens taking place in the etiologic structure of ARDs, which undoubtedly has a significant effect on the existing diagnostic and therapeutic measures for the treatment of ARDs. Clinical presentation of the disease of almost any etiology includes symptoms of pharyngitis and tonsillopharyngitis. The issue of effective treatment and prevention of acute respiratory viral infections is relevant worldwide due to the high prevalence, tendency to recurrent course and significant expenses on treatment. The main criterion for the choice of therapy is minimization of medical burden along with sufficient effectiveness of the treatment. Given the challenging choice of drugs prescribed as etiotropic therapy in the treatment of acute upper respiratory diseases in children, drugs having local anti-inflammatory and sanogenetic effects are of particular importance. The use of combination drugs is most expedient as they have a comprehensive (antimicrobial, anti-inflammatory and painkilling) effect at the same time. The article presents modern researches, as well as experience of practicing pediatricians on the choice of an optimal form of local antibacterial drugs for children of 6 years of age and older in the treatment of upper respiratory tract infections in pediatric patients.

Keywords

• acute respiratory diseases
• combined drugs
• strepsils®
• tonsillopharyngitis
• pharyngitis